FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOENDEROP, J. G. J.
Right arrow Articles by BINDELS, R. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOENDEROP, J. G. J.
Right arrow Articles by BINDELS, R. J. M.
(The FASEB Journal. 2002;16:1398-1406.)
© 2002 FASEB

Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1{alpha}-hydroxylase knockout mice

JOOST G. J. HOENDEROP, OLIVIER DARDENNE*, MONIQUE VAN ABEL1, ANNEMIETE W. C. M. VAN DER KEMP1, CAREL H. VAN OS, RENÉ ST.-ARNAUD* and RENÉ J. M. BINDELS1

Department of Cell Physiology, University Medical Centre Nijmegen, 6500 HB Nijmegen, Netherlands; and
* Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada

1Correspondence: 160 Cell Physiology, Nijmegen Centre for Molecular Life Sciences, University Medical Centre Nijmegen, P.O. Box 9101, NL-6500 HB Nijmegen, Netherlands. Express mail: M850 Room 07.048, Centrale Ontvangst Goederen, Geert Grooteplein Zuid 30, NL-6525 GA Nijmegen, Netherlands. E-mail: r.bindels{at}ncmls.kun.nl


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Pseudovitamin D-deficiency rickets (PDDR) is an autosomal disease characterized by hyperparathyroidism, rickets, and undetectable levels of 1,25-dihydroxyvitaminD3 (1,25(OH)2D3). Mice in which the 25-hydroxyvitamin D3-1{alpha}-hydroxylase (1{alpha}-OHase) gene was inactivated presented the same clinical phenotype as patients with PDDR and were used to study renal expression of the epithelial Ca2+ channel (ECaC1), the calbindins, Na+/Ca2+ exchanger (NCX1), and Ca2+-ATPase (PMCA1b). Serum Ca2+ (1.20±0.05 mM) and mRNA/protein expression of ECaC1 (41±3%), calbindin-D28K (31±2%), calbindin-D9K (58±7%), NCX1 (10±2%), PMCA1b (96±4%) were decreased in 1{alpha}-OHase-/- mice compared with 1{alpha}-OHase+/- littermates. Feeding these mice a Ca2+-enriched diet normalized serum Ca2+ levels and expression of Ca2+ proteins except for calbindin-D9K expression. 1,25(OH)2D3 repletion resulted in increased expression of Ca2+ transport proteins and normalization of serum Ca2+ levels. Localization of Ca2+ transport proteins was clearly polarized in which ECaC1 was localized along the apical membrane, calbindin-D28K in the cytoplasm, and calbindin-D9K along the apical and basolateral membranes, resulting in a comprehensive mechanism facilitating renal transcellular Ca2+ transport. This study demonstrated that high dietary Ca2+ intake is an important regulator of the renal Ca2+ transport proteins in 1,25(OH)2D3-deficient status and thus contributes to the normalization of blood Ca2+ levels.—Hoenderop, J. G. J., Dardenne, O., van Abel, M., van der Kemp, A. W. C. M., van Os, C. H., St.-Arnaud, R., Bindels, R. J. M. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1{alpha}-hydroxylase knockout mice.


Key Words: ECaC • CaT1 • vitamin D • calcium reabsorption


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
1,25-DIHYDROXYVITAMIN D3 (1,25(OH)2D3) is an important hormone in Ca2+ homeostasis and bone mineralization (1) . The genomic effects underlying part of the regulatory processes are mediated by the interaction of 1,25(OH)2D3 with the nuclear vitamin D receptor (VDR) in a ligand concentration-dependent manner (2) . 1,25(OH)2D3 is synthesized from an inactive metabolite by the renal cytochrome P450 enzyme 25-hydroxyvitamin D3-1{alpha}-hydroxylase (CYP27B1, hereafter referred to as 1{alpha}-OHase). The importance of this enzyme is reflected by severe disorders resulting from mutations in the gene coding for 1{alpha}-OHase, including pseudovitamin D-deficiency rickets (PDDR), also known as vitamin D-deficiency rickets type I (VDDR I) (3) . PDDR is an autosomal recessive disease characterized by growth retardation, failure to thrive, hypocalcemia, osteomalacia, and rickets. Recently, the genetic association of 1{alpha}-OHase with PDDR has been confirmed by deletion of the 1{alpha}-OHase gene in mice (4 , 5) .

1,25(OH)2D3 is synthesized primarily in the kidney by conversion of 25-hydroxy-vitamin D3 in the mitochondria of the proximal tubules (6) . The kidney is also an important target organ for 1,25(OH)2D3 and responsible for the regulation of the extracellular Ca2+ concentration by controlling Ca2+ excretion from the body. In normal adult animals, a major portion (>95%) of filtered Ca2+ in the kidney is reabsorbed, and only a small fraction (2%) equal to the amount of Ca2+ absorbed in the intestine is excreted in urine to maintain Ca2+ balance. Immunohistochemical studies demonstrated that the VDR is predominantly localized to the distal tubule, which is the site for 1,25(OH)2D3-controlled active Ca2+ reabsorption (7) . Ca2+ reabsorption in these segments consists of passive entry of Ca2+ across the apical membrane through the epithelial Ca2+ channel (ECaC1), cytosolic diffusion of Ca2+ bound to calbindin (calbindin-D28K and calbindin-D9K), and active extrusion of Ca2+ across the opposite basolateral membrane by the Na+/Ca2+ exchanger (NCX1) and the plasma membrane Ca2+-ATPase (PMCA1b) (8 , 9) .

The recent identification of the apical Ca2+ channel allows the development of a comprehensive study of hormonal-dependent active Ca2+ transport in the kidney, where the individual contribution of the participating proteins can be underscored (10) . Primary or secondary involvement of these Ca2+ transport proteins can be expected in several pathological situations. For example, conditions associated with a disturbed serum Ca2+ concentration, such as in PDDR, are certainly of interest due to the conspicuous presence of these Ca2+ transport proteins in the kidney; therefore, knowledge of regulation of these proteins provides new insight into Ca2+ metabolism under (patho)physiological circumstances.

The aim of the present study was to investigate the regulation of Ca2+ transport proteins in the kidney and their role in maintaining Ca2+ balance. The recently generated 1{alpha}-OHase knockout mice were used, which develop a severe hypocalcemia and represent a unique model system for PDDR. Furthermore, these mice allow to dissociate 1,25(OH)2D3-dependent from 1,25(OH)2D3-independent processes. 1{alpha}-OHase knockout mice were rescued by 1,25(OH)2D3 repletions or high dietary Ca2+ intake and the renal expression of ECaC1, calbindin-D28K, calbindin-D9K, NCX1, and PMCA1b was subsequently measured at mRNA and protein level by real-time PCR and immunoblotting and immunohistochemistry.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Animals
25-Hydroxyvitamin D3-1{alpha}-hydroxylase knockout mice were recently generated by targeted ablation of exon 8 encoding the heme binding domain of the enzyme (4) . 1{alpha}-OHase knockout mice were genotyped by Southern blot analysis at 3 wk of age directly after the weaning period as described (4) . Initial characterization of the 1{alpha}-OHase knockout mice demonstrated there are no significant differences between wild-type (1{alpha}-OHase+/+) and heterozygous 1{alpha}-OHase knockout mice (1{alpha}-OHase+/-) (4) . The heterozygous mice therefore were used as control animals. 1{alpha}-OHase+/- and homozygous 1{alpha}-OHase (1{alpha}-OHase-/-) knockout mice were fed from wk 3 to 8 either a normal diet (1.1% Ca2+, 0.8% phosphorus, 0% lactose), a Ca2+-enriched diet (2% calcium, 1.25% phosphorus, 20% lactose; Harlan Teklad, Madison, WI), or a normal diet in combination with i.p. injected 1,25(OH)2D3 repletions of 500 pg/g body weight daily in wk 3–4 and 100 pg/g daily in wk 5–8. Animals (n=6 in each group) were killed at 8 wk of age, and blood and kidney samples were taken. The animal ethics board of the University of Nijmegen (Nijmegen) and Shriners Hospital for Children (Montreal) approved all animal experimental procedures.

RNA isolation and quantitative RT-PCR
Mice were exsanguinated under anesthesia. Kidney tissue was homogenized in Trizol (Gibco, BRL, Grand Island, NY) and total RNA was isolated as specified by the manufacturer. RNA (2 µg) was reverse transcribed using Moloney murine leukemia virus reverse transcriptase (RT, Gibco, BRL). Quantitative RT-PCR reactions were performed using an ABI-prism 7700 sequence detector (Gene-Amp PCR system 9600, PE Biosystems, Foster City, CA). Sequences of PCR primers and fluorescent probes for ECaC1, calbindin-D9K, calbindin-D28K, Ca2+-ATPase (PMCA1b), Na+/Ca2+ exchanger (NCX1), and hypoxanthine-guanine phosphoribosyl transferase (HPRT) are depicted in Table 1 (11) . The amplicons were verified by sequencing. The relative expression levels of the target genes were calculated as a ratio to the HPRT gene.


View this table:
[in this window]
[in a new window]
 
Table 1. Primers and probes for quantitative reverse transcription real-time PCRa

Immunoblotting
Kidney tissue was removed, immediately frozen in liquid nitrogen, and homogenized in phosphate-buffered saline (PBS). All samples (20 µg of protein) were separated on 12% and 16% (w/v) SDS-PAGE gels and blotted to PVDF-nitrocellulose membranes (Immobilon-P, Millipore Corporation, Bedford, MA). Blots were incubated for 16 h with calbindin-D28K antibody (Sigma, 1:10,000), calbindin-D9K antibody (Swant, Switzerland, 1:10,000), or NaK-ATPase antibody (kindly provided by Dr. Moller; 1:20,000; ref 12 ). Subsequently, immunoreactive protein was detected using the enhanced chemiluminescence method as described previously (13) .

Immunofluorescence confocal microscopy
Kidney tissue was cut into pieces, placed in 1% (w/v) periodate-lysine-paraformaldehyde fixative for 2 h at room temperature and incubated overnight at 4°C in PBS containing 15% (w/v) sucrose as described previously (14) . Subsequently, kidney samples were frozen in liquid nitrogen and 7 µm frozen sections were cut for different staining procedures. The kidney sections were stained with affinity-purified guinea pig anti-ECaC antiserum (1:1000) as described previously (14) . Sections triple stained for ECaC1 and calbindins were incubated simultaneously for 16 h at 4°C with affinity-purified antiserum against ECaC1, calbindin-D9K (1:500), calbindin-D28K (1:500). To visualize ECaC1, calbindin-D28K, and calbindin-D9K, sections were stained with affinity-purified goat anti-guinea pig-biotin as described (15) , goat anti rabbit Alexa 594-conjugated anti IgG (1:300), and goat anti-mouse Cy5-conjugated anti-IgG (1:50), respectively (Molecular Probes, Eugene, OR). All negative controls, including sections incubated with preimmune serum, antiserum preabsorbed for 1 h with 10 µg/mL ECaC-GST fusion protein, or conjugated antibodies alone, were devoid of any staining. Sections were dehydrated in methanol and subsequently mounted in Mowiol (Hoechst, Frankfurt, Germany) and visualized by confocal laser scanning microscopy (MRC-1000; Bio-Rad, Richmond, CA) using a Nikon Diaphot microscope (Tokyo, Japan). The ECaC1 antibody used in this study has been extensively characterized but is, so far not reacting on immunoblots (15) . To semiquantify ECaC1, protein expression immunopositive tubules in 10 random microscopic fields were counted for each condition as described (15) .

Biochemical assays
Serum 1,25(OH)2D3 levels were measured using a specific RIA (ImmunoDiognostic Systems Ltd., Boldon, UK). Total calcium was measured using a Monarch automated analyzer (4) .

Statistical analysis
The data are expressed as the mean ± SE. Overall statistical significance was determined by analysis of variance. In the case of significance (P<0.05), individual groups were compared by contrast analysis according to Scheffé.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Inactivation of both alleles of the 1{alpha}-OHase gene (1{alpha}-OHase-/-) resulted in severe hypocalcemia with plasma Ca2+ concentrations as low as 1.2 mM, in contrast to the heterozygous littermates, which exhibit normal plasma Ca2+ concentrations (Table 2 ). Supplementation of hypocalcemic 1{alpha}-OHase-/- mice with 1,25(OH)2D3 or a high dietary Ca2+ intake normalized the plasma Ca2+ concentration.


View this table:
[in this window]
[in a new window]
 
Table 2. The effect of normal diet, Ca2+-enriched diet and 1,25(OH)2D3-supplemented diet on serum Ca2+ concentration in 1{alpha}-OHase knockout micea

To determine the molecular mechanism responsible for the severe hypocalcemia in 1{alpha}-OHase-/- mice, renal expression of ECaC1, calbindin-D28K, calbindin-D9K, NCX1, and PMCA1b in 1{alpha}-OHase-/- and 1{alpha}-OHase+/- knockout mice was examined. Using quantitative real-time PCR, a twofold decrease in ECaC1 mRNA levels was observed in kidneys of 1{alpha}-OHase-/- compared with 1{alpha}-OHase+/- mice (Fig. 1 A). Down-regulation of ECaC1 was accompanied by a decrease in calbindin-D28K (3-fold) and calbindin-D9K (2-fold) mRNA (Fig. 1B, C ). The high dietary Ca2+ diet restored the low ECaC1 and calbindin-D28K mRNA levels in the 1{alpha}-OHase-/- mice. In contrast, the expression was decreased in the heterozygous littermates by the high Ca2+ diet (Fig. 1A, B ). Calbindin-D9K mRNA was decreased in kidney of 1{alpha}-OHase-/- mice whereas this transcript was not up-regulated by high dietary Ca2+ intake (Fig. 1C ). Subsequently, regulation of the basolateral extrusion transporters was studied. The most important Ca2+ extrusion mechanism in the distal part of the nephron is NCX1, and this exchanger was severely down-regulated in kidneys from 1{alpha}-OHase-/- mice. Again, similar to ECaC1 and calbindin-D28K, this transcript was up-regulated by dietary Ca2+ intake whereas Ca2+ supplementation had no effect on the expression of the exchanger in 1{alpha}-OHase+/- (Fig. 1D ). mRNA encoding PMCA1b is not significantly reduced in kidneys of 1{alpha}-OHase-/- mice (Fig. 1E ). High dietary Ca2+ intake, however, resulted in a significant increase in expression. Supplementation of the 1{alpha}-OHase-/- mice with 1,25(OH)2D3 significantly increased mRNA expression levels of all the Ca2+ transport molecules measured including ECaC1, calbindin-D28K, calbindin-D9K, NCX1, and PMCA1b (Fig. 1) .



View larger version (31K):
[in this window]
[in a new window]
 
Figure 1. Gene expression patterns in kidney of 1{alpha}-OHase-/- (filled bars) and 1{alpha}-OHase+/- (open bars) mice on normal diet, Ca2+-enriched diet, and the 1,25(OH)2D3-supplemented diet. Renal expression of ECaC1 (A), calbindin-D28K (B), calbindin-D9K (C), NCX1 (D), and PMCA1b (E) assessed by real-time PCR analysis is calculated as a ratio to the HPRT RNA level and expressed relative to levels of 1{alpha}-OHase+/- mice on a normal diet. Values are presented as means ± SE (n=6). *P < 0.05, significant from 1{alpha}-OHase+/- mice on a normal diet. #P < 0.05, significant from 1{alpha}-OHase-/- mice on a normal diet.

Expression of Ca2+ transport proteins was studied at the protein level. First, the abundance of ECaC1 protein was examined. ECaC1 immunopositive tubules in 10 random microscopic fields of kidney cortex were counted semiquantitatively for each animal (15) . Figure 2 depicts the average values obtained for four 1{alpha}-OHase knockout mice. Inactivating the 1,25(OH)2D3 gene in 1{alpha}-OHase-/- mice had a major effect on ECaC1 protein expression as indicated by the low number of immunopositive distal tubules in the kidney cortex. Normalization of the 1,25(OH)2D3 levels or high dietary Ca2+ intake restored ECaC1 expression to levels comparable to those observed in 1{alpha}-OHase+/- mice (Fig. 2) . In agreement with the reduced ECaC1 mRNA expression, this Ca2+-enriched diet lowered protein expression in 1{alpha}-OHase+/- mice. Immunoblotting showed a significant down-regulation of calbindin-D28K and calbindin-D9K protein abundance in the 1{alpha}-OHase-/- mice (Fig. 3 ). The decrease in calbindin-D28K protein was recovered by high dietary Ca2+ intake whereas calbindin-D9K expression was not altered. Calbindin protein expression levels were completely restored in 1{alpha}-OHase-/- mice after repletion with 1,25(OH)2D3. The corresponding Na+-K+-ATPase bands did not vary significantly in density, which precludes unequal loading as an explanation for the differences (Fig. 3) .



View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. A) Immunofluorescence localization of ECaC1 in kidney (depicted in white) of 1{alpha}-OHase+/- and 1{alpha}-OHase-/- mice on normal diet, Ca2+-enriched diet and the 1,25(OH)2D3-supplemented diet. B) Semiquantitative results were obtained by counting randomly 10 microscopic fields for ECaC1 immunopositive distal tubular segments in kidney cortex of 1{alpha}-OHase+/- (open bars) and 1{alpha}-OHase-/- (filled bars) mice. Values are presented as means ± SE (n=6). *P < 0.05, significant from 1{alpha}-OHase+/- mice on a normal diet. #P < 0.05, significant from 1{alpha}-OHase-/- mice on a normal diet. Bar is 25 µm.



View larger version (74K):
[in this window]
[in a new window]
 
Figure 3. Effects of normal diet, Ca2+-enriched diet and 1,25(OH)2D3-supplemented diet on calbindin-D28K and calbindin-D9K expression in kidney of 1{alpha}-OHase-/- and 1{alpha}-OHase+/- mice. Immunoblots were run with 20 µg of protein per lane of whole-kidney homogenates and probed with anti-calbindin-D28K or anti-calbindin-D9K. Immunoblots were probed with an antibody against Na+-K+-ATPase (12) to exclude the possibility that the difference in calbindin expression was due to unequal loading.

Figure 4 shows representative triple immunofluorescence labeling of distal tubules in mice kidney cortex sections stained for ECaC1 (green), calbindin-D28K (blue), and calbindin-D9K (red). Superimposed images showed colocalization of these Ca2+ transport proteins in 1{alpha}-OHase-/- and 1{alpha}-OHase+/- mice, both on a normal diet. Moreover, kidneys of 1,25(OH)2D3-repleted mice clearly indicate an increased number of ECaC1 and calbindins immunopositive distal tubules; identical to the normal diet, a remarkable overlap was apparent. High dietary Ca2+ intake by 1{alpha}-OHase-/- mice increased the amount of immunopositive tubules expressing ECaC1 and calbindin-D28K; the expression of calbindin-D9K was not significantly altered and distal tubules were observed that express exclusively calbindin-D28K, a phenomenon that was never seen in mice fed the control diet or repleted with 1,25(OH)2D3 (Fig. 4 , asterisks). Higher magnifications showed that ECaC1 is predominantly localized to the apical domain of distal tubular segments. In these immunopositive tubules, calbindin-D28K was observed throughout the cytosol. Intriguingly, the immunofluorescence staining of calbindin-D9K appeared to be more compartmentalized and associated with apical and basolateral membranes (Fig. 5 ).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 4. Localization of Ca2+ transport proteins in kidney of 1{alpha}-OHase-/- and 1{alpha}-OHase+/- mice. Effect of normal diet, Ca2+-enriched diet and 1,25(OH)2D3-supplemented diet on the expression pattern of ECaC1 (green), calbindin-D28K (blue) and calbindin-D9K (red). Bar is 100 µm.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 5. Immunofluorescence triple staining of a mice kidney cortex section depicting the cellular localization of ECaC1 (green), calbindin-D28K (blue) and calbindin-D9K (red) in distal tubules. A glomerulus is depicted in the image (G). Bar is 25 µm.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The present study demonstrates that the expression of the renal Ca2+ transport proteins ECaC1, calbindin-D28K, calbindin-D9K and NCX1 is significantly down-regulated in the kidney of 1{alpha}-OHase-/- mice, which is in line with a diminished Ca2+ reabsorption capacity contributing to the development of hypocalcemia. Furthermore, high dietary Ca2+ intake restored the decreased expression of Ca2+ transport proteins independent of 1,25(OH)2D3 and normalized the serum Ca2+ concentration.

Recently two laboratories independently generated 1{alpha}-OHase knockout mice strains that represent valuable animal models for PDDR since they display undetectable 1,25(OH)2D3 concentrations, hypocalcemia, secondary hyperparathyroidism, and failure to thrive (4 , 5) . The 1{alpha}-OHase-/- mice developed distinct histological evidence of rickets and osteomalacia. There was a correlative relationship between the expression level of these Ca2+ transport proteins and blood Ca2+ levels. Normalization of the plasma Ca2+ level by 1,25(OH)2D3 or Ca2+ supplementation was associated with an increase in the expression level of the renal Ca2+ transport proteins, confirming the essential role of these proteins in active hormone-mediated Ca2+ transport and maintaining Ca2+ balance. These findings imply that in addition to intestinal Ca2+ absorption, the kidney also plays a crucial role in maintaining body Ca2+ homeostasis. This follows from experiments performed with VDR knockout mice. In these hypocalcemic mice, urinary Ca2+ excretion is inappropriately high, suggesting renal Ca2+ wasting due to disturbed Ca2+ reabsorption (11 , 16 , 17) . Taken together, in 1{alpha}-OHase-/- and VDR-/- mice the sustained hypocalcemia is related to defective distal Ca2+ reabsorption.

The reduced expression level of Ca2+ transport proteins in the 1{alpha}-OHase-/- mice was restored by high dietary Ca2+ intake and accompanied by normalization of serum Ca2+ concentrations. This effect was observed in the absence of 1{alpha}-OHase-activity. In contrast, the Ca2+-enriched diet reduced the expression of Ca2+ transport proteins in 1{alpha}-OHase+/- mice, which exhibit normal serum vitamin D and Ca2+ levels. Under physiological conditions, Ca2+ acts via a negative feedback mechanism that eventually leads to suppression of the 1{alpha}-OHase-activity, which decreases Ca2+ reabsorption and expression of Ca2+ transport proteins (3) .

Our study with 1{alpha}-OHase-/- mice has revealed that Ca2+ supplementation can up-regulate gene transcription encoding for Ca2+ transporters in the absence of circulating 1,25(OH)2D3, but the molecular mechanism of this vitamin D-independent Ca2+-sensitive pathway remains elusive. It is likely, however, that Ca2+-responsive elements are present in the promoter regions of the ECaC1 and calbindin genes in addition to the identified vitamin D-responsive ones (15 , 18 , 19) . Several elements have been proposed to function as Ca2+-sensitive transcriptional regulators, including the serum-responsive element and the cAMP/Ca2+-responsive element (20) . Of interest is the identification by Arnold and Heintz of a Purkinje cell expression specific element (PCE1) in the calbindin-D28K gene that functions as a Ca2+-sensitive transcriptional regulatory mechanism (21) . This mechanism may play a role in fine-tuning the Ca2+ buffer capacity of Purkinje cells. Since these elements could not be found in the 5' upstream region of the ECaC1 and NCX1 gene, this Ca2+-sensitive transcriptional mechanism could only apply to the calbindin-D28K up-regulation reported here.

Recovery of expression of Ca2+ transport proteins and normalization of the plasma Ca2+ concentration by high dietary Ca2+ intake were associated with a dissociation in the localization of the calbindins in kidney cortex. In the 1{alpha}-OHase mutant mice, calbindin-D28K was up-regulated by Ca2+ and present in more cells than calbindin-D9K, whose amount and localization was not altered. Most of the distal tubular segments coexpress ECaC1 and calbindin-D28K, but a subpopulation of distal tubules was identified that expresses calbindin-D28K. Histochemical studies in mouse and rat kidney revealed only the highest expression of ECaC1 and calbindin-D28K in most of the distal convoluted tubule (DCT2) and connecting tubule; in these segments, both proteins colocalize (15 , 22) . Prominent NCX1 and PMCA1b immunostaining was exactly congruent with that of ECaC1 immunostaining (22) . Staining of the three latter proteins abruptly disappeared at the transition to the cortical collecting duct, whereas staining of calbindin-D28K continued along the CCD (22) . These latter tubules do express calbindin-D28K at higher levels after feeding the mice a Ca2+-enriched diet. This raises the intriguing question of whether calbindin-D28K can exert additional functions in these latter segments besides its known function of Ca2+ diffusion facilitation.

It is essential that the number of ECaC1 channels at the plasma membrane is matched by the cytosolic Ca2+ buffering capacity of these cells since the activity of ECaC1 is tightly controlled by the ambient Ca2+ concentration (23 , 24) . The necessity of sufficient Ca2+ buffering is underscored by the conspicuous colocalization of ECaC1, the calbindins, NCX1, and PMCA1b in Ca2+ transporting epithelial cells (14 , 22) . The 1,25(OH)2D3 responsiveness of ECaC1 and calbindins is in line with previous studies. Until now there has been only limited data available regarding regulation of the basolateral extrusion systems by vitamin D. Similar to ECaC1 and the calbindins, an impressive reduction of NCX1 was observed but no significant down-regulation of PMCA1b was measured. Van Baal et al. concluded that Na+/Ca2+ exchange is the primary Ca2+ extrusion mechanism, whereas only a minor amount of Ca2+ in the distal tubular cells is extruded by the plasma Ca2+ pump (25) . These findings point to a crucial role of the exchanger in vitamin D-dependent Ca2+ reabsorption. The present observation that ECaC1, calbindins, NCX1, and, to a lesser extent, PMCA1b, are synchronically controlled by 1,25(OH)2D3 demonstrates the intimate relation between apical Ca2+ influx, cytosolic Ca2+ diffusion, and basolateral Ca2+ extrusion during 1,25(OH)2D3-stimulated Ca2+ reabsorption.

Several pathological symptoms in 1{alpha}-OHase-/- and VDR-/- mice are similar including severe hypocalcemia, hyperparathyroidism and rickets, but there are distinctive differences between both mouse models. Renal expression of Ca2+ transport proteins was consistently decreased in 1{alpha}-OHase-/- mice whereas different effects were reported in VDR-/- mice (11 , 26) . Obviously, 1,25(OH)2D3 levels are exceptionally elevated in VDR-/- mice, whereas in 1{alpha}-OHase-/- mice its synthesis is impaired (4 , 5 , 11 , 17 , 27) . In addition to the VDR-mediated genomic pathway, many studies describe the existence of another nongenomic pathway regulated by 1,25(OH)2D3. There are indications that 1,25(OH)2D3 stimulates passive paracellular Ca2+ transport in VDR-/- mice to compensate for the reduction in Ca2+ reabsorption (28) . Furthermore, 1,25(OH)2D3 has been implicated in the stabilization of mRNA (29) , regulation of voltage-gated and store-operated Ca2+ channels (30 , 31) , opening of chloride channels (32) , modulation of protein kinase C activity (33) and activation of mitogen-activated protein kinases (34) , which eventually lead to the onset of rapid or long-term biological responses. Recent studies have indicated that the generation of these rapid responses could be mediated via a putative membrane receptor with ligand binding properties different from those of the nuclear VDR (35 36 37) . As an alternative to a specific membrane receptor for 1,25(OH)2D3, it has been suggested that membrane-associated annexin II might serve as a receptor for 1,25(OH)2D3-mediated responses (38 , 39) . It is conceivable that these 1,25(OH)2D3-mediated nongenomic pathways will influence the expression and activity of Ca2+ transport proteins in the kidney and, therefore, the 1{alpha}-OHase-/- mouse is an ideal mouse model to study the effect of dietary Ca2+ independent of the 1,25(OH)2D3 regulation of transcellular Ca2+ transport in kidney.

Our study provides new insights into the localization of Ca2+ transport proteins resulting in a more comprehensive molecular model for active Ca2+ reabsorption in the distal part of the nephron (Fig. 6 ). ECaC1 is predominantly localized along the apical membrane and facilitates the first step in this active transport process. The uniform distribution of calbindin-D28K throughout the cytosol is in accordance with the postulated physiological role as a cytosolic Ca2+ buffer and as a shuttle mechanism between the luminal influx and the basolateral efflux sites (Fig. 6) . The efflux of Ca2+ is facilitated mainly by Na+/Ca2+ exchange and to a lesser extent by the ATP-dependent Ca2+ pump (25) . The conspicuous localization of calbindin-D9K along the basolateral and apical membranes excludes a cytosolic Ca2+ shuttle function. Alternatively, calbindin-D9K could distribute Ca2+ quickly along the plane of the plasma membrane after influx through a few scattered Ca2+ channels and supply sufficient Ca2+ to a small number of extrusion proteins (Fig. 6) .



View larger version (86K):
[in this window]
[in a new window]
 
Figure 6. Model of transcellular Ca2+ transport by cells lining the distal part of the nephron. Entry of Ca2+ is facilitated by the apical Ca2+ channel ECaC1. Subsequently, the ion binds to calbindin-D9K (light gray) or directly to calbindin-D28K (dark gray) and diffuses through the cytosol to the basolateral membrane. Ca2+ ions are extruded, directly or via intermission of calbindin-D9K, by a Na+/Ca2+ exchanger (NCX1) and a Ca2+-ATPase (PMCA1b).

In conclusion, the present study demonstrate that high dietary Ca2+ intake is an important regulator of the renal Ca2+ transport proteins in 1,25(OH)2D3-deficient status and thus contributes to the normalization of blood Ca2+ levels. The treatment of choice for PDDR patients is long-term replacement therapy with 1,25(OH)2D3. Repletion with vitamin D analogs has proved to be beneficial in various clinical situations such as the prevention of rickets during infancy. It will therefore be of interest to compare the benefits of supplemented dietary Ca2+ to long-term treatment with vitamin D analogs.


   ACKNOWLEDGMENTS
 
This work was supported by the Dutch Organization of Scientific Research (Zon-Mw 016.006.001, Zon-Mw 902.18.298), Dutch Kidney Foundation (C10.1881), and the Shriners of North America. R.S.-A. is a ‘chercheur-boursier’ from the Fonds de la Recherche en Santé du Québec.

Received for publication March 13, 2002. Revision received May 16, 2002.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Reichel, H., Koeffler, H. P., Norman, A. W. (1989) The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320,980-991[Medline]
  2. Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J. C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., Jurutka, P. W. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13,325-349[CrossRef][Medline]
  3. Takeyama, K., Kitanaka, S., Sato, T., Kobori, M., Yanagisawa, J., Kato, S. (1997) 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277,1827-1830[Abstract/Free Full Text]
  4. Dardenne, O., Prud’homme, J., Arabian, A., Glorieux, F. H., St.-Arnaud, R. (2001) Targeted inactivation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142,3135-3141[Abstract/Free Full Text]
  5. Panda, D. K., Miao, D., Tremblay, M. L., Sirois, J., Farookhi, R., Hendy, G. N., Goltzman, D. (2001) Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 98,7498-7503[Abstract/Free Full Text]
  6. Lawson, D. E., Fraser, D. R., Kodicek, E., Morris, H. R., Williams, D. H. (1971) Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature (London) 230,228-230[CrossRef][Medline]
  7. Kumar, R., Schaefer, J., Grande, J. P., Roche, P. C. (1994) Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P-450, and calbindin D28k in human kidney. Am. J. Physiol. 266,F477-F485[Abstract/Free Full Text]
  8. Hoenderop, J. G., Willems, P. H., Bindels, R. J. (2000) Toward a comprehensive molecular model of active calcium reabsorption. Am. J. Physiol. 278,F352-F360
  9. Hoenderop, J. G., Nilius, B., Bindels, R. J. (2002) Molecular mechanisms of active Ca2+ reabsorption in the distal nephron. Annu. Rev. Physiol. 64In press
  10. Hoenderop, J. G., van der Kemp, A. W., Hartog, A., van de Graaf, S. F., van Os, C. H., Willems, P. H., Bindels, R. J. (1999) Molecular identification of the apical Ca2+ channel in 1,25-dihydroxyvitamin D3-responsive epithelia. J. Biol. Chem. 274,8375-8378[Abstract/Free Full Text]
  11. van Cromphaut, S., Dewerchin, M., Hoenderop, J. G., Stockmans, I., van Herck, E., Kato, S., Bindels, R. J., Collen, D., Carmeliet, P., Bouillon, R., Carmeliet, G. (2001) Active duodenal calcium absorption in vitamin D receptor-knock out mice: functional and molecular aspects. Proc. Natl. Acad. Sci. USA 98,13324-13329[Abstract/Free Full Text]
  12. Ning, G., Maunsbach, A. B., Lee, Y. J., Moller, J. V. (1993) Topology of Na,K-ATPase alpha subunit epitopes analyzed with oligopeptide-specific antibodies and double-labeling immunoelectron microscopy. FEBS Lett. 336,521-524[CrossRef][Medline]
  13. Hoenderop, J. G., Vaandrager, A. B., Dijkink, L., Smolenski, A., Gambaryan, S., Lohmann, S. M., de Jonge, H. R., Willems, P. H., Bindels, R. J. (1999) Atrial natriuretic peptide-stimulated Ca2+ reabsorption in rabbit kidney requires membrane-targeted, cGMP-dependent protein kinase type II. Proc. Natl. Acad. Sci. USA 96,6084-6089[Abstract/Free Full Text]
  14. Hoenderop, J. G., Hartog, A., Stuiver, M., Doucet, A., Willems, P. H., Bindels, R. J. (2000) Localization of the epithelial Ca2+ channel in rabbit kidney and intestine. J. Am. Soc. Nephrol. 11,1171-1178[Abstract/Free Full Text]
  15. Hoenderop, J. G., Muller, D., Van Der Kemp, A. W., Hartog, A., Suzuki, M., Ishibashi, K., Imai, M., Sweep, F., Willems, P. H., Van Os, C. H., Bindels, R. J. (2001) Calcitriol controls the epithelial calcium channel in kidney. J. Am. Soc. Nephrol. 12,1342-1349[Abstract/Free Full Text]
  16. Li, Y. C., Bolt, M. J., Cao, L. P., Sitrin, M. D. (2001) Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am. J. Physiol. 281,E558-E564[Abstract/Free Full Text]
  17. Li, Y. C., Pirro, A. E., Amling, M., Delling, G., Baron, R., Bronson, R., Demay, M. B. (1997) Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 94,9831-9835[Abstract/Free Full Text]
  18. Muller, D., Hoenderop, J. G., Merkx, G. F., van Os, C. H., Bindels, R. J. (2000) Gene structure and chromosomal mapping of human epithelial calcium channel. Biochem. Biophys. Res. Commun. 275,47-52[CrossRef][Medline]
  19. Gill, R. K., Christakos, S. (1993) Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses. Proc. Natl. Acad. Sci. USA 90,2984-2988[Abstract/Free Full Text]
  20. Gallin, W. J., Greenberg, M. E. (1995) Calcium regulation of gene expression in neurons: the mode of entry matters. Curr. Opin. Neurobiol. 5,367-374[CrossRef][Medline]
  21. Arnold, D. B., Heintz, N. (1997) A calcium responsive element that regulates expression of two calcium binding proteins in Purkinje cells. Proc. Natl. Acad. Sci. USA 94,8842-8847[Abstract/Free Full Text]
  22. Loffing, J., Loffing-Cueni, D., Valderrabano, V., Klausli, L., Hebert, S. C., Rossier, B. C., Hoenderop, J. G., Bindels, R. J., Kaissling, B. (2001) Organization of the mouse distal nephron: distributions of transcellular calcium and sodium transport pathways. Am. J. Physiol. 281,F1021-F1027[Abstract/Free Full Text]
  23. Vennekens, R., Hoenderop, J. G., Prenen, J., Stuiver, M., Willems, P. H., Droogmans, G., Nilius, B., Bindels, R. J. (2000) Permeation and gating properties of the novel epithelial Ca2+ channel. J. Biol. Chem. 275,3963-3969[Abstract/Free Full Text]
  24. Nilius, B., Prenen, J., Vennekens, R., Hoenderop, J. G., Bindels, R. J., Droogmans, G. (2001) Modulation of the epithelial calcium channel, ECaC, by intracellular Ca2+. Cell Calcium 29,417-428[CrossRef][Medline]
  25. Van Baal, J., Yu, A., Hartog, A., Fransen, J. A., Willems, P. H., Lytton, J., Bindels, R. J. (1996) Localization and regulation by vitamin D of calcium transport proteins in rabbit cortical collecting system. Am. J. Physiol. 271,F985-F993[Abstract/Free Full Text]
  26. Weber, K., Erben, R. G., Rump, A., Adamski, J. (2001) Gene structure and regulation of the murine epithelial calcium channels ECaC1 and 2. Biochem. Biophys. Res. Commun. 289,1287-1294[CrossRef][Medline]
  27. Yoshizawa, T., Handa, Y., Uematsu, Y., Takeda, S., Sekine, K., Yoshihara, Y., Kawakami, T., Arioka, K., Sato, H., Uchiyama, Y., Masushige, S., Fukamizu, A., Matsumoto, T., Kato, S. (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16,391-396[CrossRef][Medline]
  28. Chirayath, M. V., Gajdzik, L., Hulla, W., Graf, J., Cross, H. S., Peterlik, M. (1998) Vitamin D increases tight-junction conductance and paracellular Ca2+ transport in Caco-2 cell cultures. Am. J. Physiol. 274,G389-G396[Abstract/Free Full Text]
  29. Theofan, G., Norman, A. W. (1986) Effects of alpha-amanitin and cycloheximide on 1,25-dihydroxyvitamin D3-dependent calbindin-D28K and its mRNA in vitamin D3-replete chick intestine. J. Biol. Chem. 261,7311-7315[Abstract/Free Full Text]
  30. Norman, A. W., Bouillon, R., Farach-Carson, M. C., Bishop, J. E., Zhou, L. X., Nemere, I., Zhao, J., Muralidharan, K. R., Okamura, W. H. (1993) Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. J. Biol. Chem. 268,20022-20030[Abstract/Free Full Text]
  31. Vazquez, G., de Boland, A. R., Boland, R. L. (2000) Involvement of calmodulin in 1alpha,25-dihydroxyvitamin D3 stimulation of store-operated Ca2+ influx in skeletal muscle cells. J. Biol. Chem. 275,16134-16138[Abstract/Free Full Text]
  32. Zanello, L. P., Norman, A. W. (1997) Stimulation by 1alpha,25(OH)2-vitamin D3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-function study. J. Biol. Chem. 272,22617-22622[Abstract/Free Full Text]
  33. Norman, A. W., Henry, H. L., Bishop, J. E., Song, X. D., Bula, C., Okamura, W. H. (2001) Different shapes of the steroid hormone 1alpha,25(OH)(2)-vitamin D(3) act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 66,147-158[CrossRef][Medline]
  34. de Boland, A. R., Norman, A. W. (1998) 1alpha,25(OH)2-vitamin D3 signaling in chick enterocytes: enhancement of tyrosine phosphorylation and rapid stimulation of mitogen-activated protein (MAP) kinase. J. Cell. Biochem. 69,470-482[CrossRef][Medline]
  35. Baran, D. T., Ray, R., Sorensen, A. M., Honeyman, T., Holick, M. F. (1994) Binding characteristics of a membrane receptor that recognizes 1 alpha,25-dihydroxyvitamin D3 and its epimer, 1 beta,25-dihydroxyvitamin D3. J. Cell. Biochem. 56,510-517[CrossRef][Medline]
  36. Nemere, I., Dormanen, M. C., Hammond, M. W., Okamura, W. H., Norman, A. W. (1994) Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem. 269,23750-23756[Abstract/Free Full Text]
  37. Kato, A., Bishop, J. E., Norman, A. W. (1998) Evidence for a 1 alpha,25-dihydroxyvitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Biochem. Biophys. Res. Commun. 244,724-727[CrossRef][Medline]
  38. Kim, Y. S., MacDonald, P. N., Dedhar, S., Hruska, K. A. (1996) Association of 1 alpha,25-dihydroxyvitamin D3-occupied vitamin D receptors with cellular membrane acceptance sites. Endocrinology 137,3649-3658[Abstract]
  39. Baran, D. T., Quail, J. M., Ray, R., Honeyman, T. (2000) Binding of 1alpha,25-dihydroxyvitamin D3 to annexin II: effect of vitamin D metabolites and calcium. J. Cell. Biochem. 80,259-265[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOENDEROP, J. G. J.
Right arrow Articles by BINDELS, R. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOENDEROP, J. G. J.
Right arrow Articles by BINDELS, R. J. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS